Package 61755-014-01

Brand: veopoz

Generic: pozelimab
NDC Package

Package Facts

Identity

Package NDC 61755-014-01
Digits Only 6175501401
Product NDC 61755-014
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (61755-014-01) / 2 mL in 1 VIAL, SINGLE-DOSE (61755-014-00)

Marketing

Marketing Status
Marketed Since 2023-08-18
Brand veopoz
Generic pozelimab
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "a8be5cf0-49ba-4795-a2e5-7ea07f495958", "openfda": {"nui": ["N0000175575", "N0000175974"], "unii": ["0JJ21K6L2I"], "rxcui": ["2663945", "2663952"], "spl_set_id": ["a8d6f10e-9430-450a-a3dd-b538f9b2a308"], "pharm_class_epc": ["Complement Inhibitor [EPC]"], "pharm_class_moa": ["Complement Inhibitors [MoA]"], "manufacturer_name": ["Regeneron Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (61755-014-01)  / 2 mL in 1 VIAL, SINGLE-DOSE (61755-014-00)", "package_ndc": "61755-014-01", "marketing_start_date": "20230818"}], "brand_name": "VEOPOZ", "product_id": "61755-014_a8be5cf0-49ba-4795-a2e5-7ea07f495958", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Complement Inhibitor [EPC]", "Complement Inhibitors [MoA]"], "product_ndc": "61755-014", "generic_name": "Pozelimab", "labeler_name": "Regeneron Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VEOPOZ", "active_ingredients": [{"name": "POZELIMAB", "strength": "200 mg/mL"}], "application_number": "BLA761339", "marketing_category": "BLA", "marketing_start_date": "20230818", "listing_expiration_date": "20261231"}